Related Experiment Video

Updated: May 11, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Comment on 'High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'

C Ho-Yen, R L Bowen, S Kermorgant

    British Journal of Cancer
    |May 16, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    Related Experiment Videos

    Last Updated: May 11, 2026

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
    11:34

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

    Published on: December 5, 2017

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    Related Concept Videos

    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Cross-tissue immune cell analysis reveals tissue-specific features in humans.

    Science (New York, N.Y.)·2022

    A method to isolate and cryopreserve cerebrospinal fluid mononuclear cells from external ventricular drains to investigate immunological processes in acute brain injuries.

    Journal of immunological methods·2021

    Risk factors for Toxoplasma gondii seropositivity in the Old Order Amish.

    Epidemiology and infection·2020

    The immunological response to traumatic brain injury.

    Journal of neuroimmunology·2019

    Day-case bilateral sagittal split osteotomy.

    The British journal of oral & maxillofacial surgery·2018

    Abnormalities of age-related T cell senescence in Parkinson's disease.

    Journal of neuroinflammation·2018

    Why early pathology input matters in biologically rich cancer trials.

    British journal of cancer·2026

    ATR inhibitors synergise with mitomycin C to enhance cytotoxicity in patient-derived non-muscle invasive bladder cancer organoids.

    British journal of cancer·2026

    Prospective validation of a urine-based proteomics test for predicting clinically significant prostate cancer in biopsy-naïve patients.

    British journal of cancer·2026

    On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort.

    British journal of cancer·2026

    Risk prediction model for brain metastasis risk among patients diagnosed with primary gastrointestinal cancers.

    British journal of cancer·2026

    The role of DNA mismatch repair status in oesophagogastric cancer treated with perioperative chemotherapy: evidence from the MRC ST03 and OE05 trials.

    British journal of cancer·2026

    Quantitative Apparent Diffusion Coefficient (ADC) Mapping as a Preoperative Biomarker for Tumor Grade and Myometrial Invasion in Endometrial Carcinoma.

    Annals of African medicine·2026

    Assessment of Phenotype, Oxidative Stress and Biomacromolecule Oxidation in Human Chronic Skin Wound Epidermis in Active Debridement Tissue Versus Endstage Wounds.

    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2026

    Clinical Significance, Immune Infiltration Landscape, and Functional Network Analysis of miR-192-5p in Colorectal Cancer.

    Journal of visualized experiments : JoVE·2026

    Non-parametric differential methylation analysis characterizes histotype-specific promoter regions in epithelial ovarian cancer.

    Epigenetics·2026

    Residential location shapes initial prostate cancer care in Korea (2010-2020): A nationwide stage- and risk-stratified study.

    Investigative and clinical urology·2026

    Predictors of active surveillance discontinuation in prostate cancer: Large Korean multicenter cohort study.

    Investigative and clinical urology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us